TriSalus Life Sciences (TLSIW) Other Accumulated Expenses (2022 - 2026)

TriSalus Life Sciences (TLSIW) has 5 years of Other Accumulated Expenses data on file, last reported at $269000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses fell 36.85% year-over-year to $269000.0; the trailing twelve-month figure through Mar 2026 stood at $269000.0 (down 36.85% YoY), and the FY2025 full-year result was $234000.0, down 38.9% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $269000.0, up from $234000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $427000.0 in Q3 2023 and bottomed at $142000.0 in Q4 2022.
• The 5-year median for Other Accumulated Expenses is $280000.0 (2024), against an average of $299583.3.
• The widest annual swing landed in 2023, when Other Accumulated Expenses soared 173.94%; it then slumped 38.9% in 2025.
• A 5-year view of Other Accumulated Expenses shows it stood at $142000.0 in 2022, then jumped by 173.94% to $389000.0 in 2023, then declined by 1.54% to $383000.0 in 2024, then slumped by 38.9% to $234000.0 in 2025, then rose by 14.96% to $269000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $269000.0 (Q1 2026), $234000.0 (Q4 2025), and $224000.0 (Q3 2025), per Business Quant data.

Peer Comparison